Bravecto 112.5 mg (Fluralaner SOLUTION) 112.5 MG

Bravecto 112.5 mg is a topical solution containing fluralaner, designed for flea and tick prevention in pets. This long-lasting treatment offers protection against common parasites, ensuring your pet's comfort and health.

Strength

112.5 MG

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bravecto 112.5 mg is primarily used for flea and tick prevention in pets. It is applied topically and provides extended protection against these parasites. Pet owners often ask, 'What is Bravecto used for?' This solution helps maintain your pet's well-being by targeting fleas and ticks, which can cause discomfort and health issues.

Side Effects

Bravecto 112.5 mg works by targeting the nervous system of fleas and ticks, leading to their paralysis and eventual death. This action helps to break the lifecycle of these parasites, providing long-lasting protection for your pet. Some pets may experience mild skin irritation at the application site.

Precautions & Warnings

Always follow the instructions provided by your veterinarian when using Bravecto 112.5 mg. Ensure the solution is applied correctly to avoid accidental ingestion or contact with the eyes. Keep the product out of reach of children and other pets. If your pet has a history of skin allergies, consult your vet before use.

Avoid Interactions

Bravecto 112.5 mg may interact with other topical treatments or medications. Avoid using other flea and tick products simultaneously unless directed by a veterinarian. Always inform your vet about any other medications your pet is taking to prevent potential interactions.

Frequently Asked Questions

Bravecto 112.5 mg is used for flea and tick prevention in pets, providing long-lasting protection against these parasites.

The application frequency depends on your pet's specific needs and the recommendations of your veterinarian.

Consult your veterinarian to determine if Bravecto 112.5 mg is suitable for your puppy, as it depends on their age and health status.

If your pet shows signs of an allergic reaction, such as excessive itching or swelling, contact your veterinarian immediately.

Bravecto 112.5 mg is specifically formulated for dogs. Do not use it on cats unless directed by a veterinarian.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.